(26 days)
The display is intended to be used in displaying digital images, including standard and multiframe digital mammography, for review, analysis, and diagnosis by trained medical practitioners. It is specially designed for breast tomosynthesis applications.
The MDNC-12130 (Nio Fusion 12MP) is a medical computer display designed for both PACS and breast imaging applications. It consists of a 30.9" 12 mega-pixel (4200x2800 resolution) LCD panel with integrated LED backlight. The panel is integrated into the display housing body with an internal mechanics chassis structure, that also integrates the electronics, sensors and power supply. The display module is supported by a display stand. Internal sensors and controllers measure, control and stabilize the device. SoftGlow Lights are integrated as an ancillary function for user comfort and can be lit to illuminate the desk and to create some ambient lighting in the reading room.
This document is a 510(k) Premarket Notification from Barco N.V. to the FDA for their Nio Fusion 12MP (MDNC-12130) display. The document focuses on demonstrating substantial equivalence to a predicate device, the Nio Color 5.8MP (MDNC-6121).
Here's an analysis of the acceptance criteria and the study proving the device meets those criteria, based on the provided text:
Acceptance Criteria and Reported Device Performance
The acceptance criteria for this device are fundamentally based on demonstrating substantial equivalence to a legally marketed predicate device (Nio Color 5.8MP) by showing that the differences in technological characteristics do not raise new questions of safety or effectiveness. The performance testing conducted is to confirm that the new device maintains similar or better performance characteristics compared to the predicate, especially given its specific indication for breast tomosynthesis.
Since this is a medical display, the "performance" is largely about its optical and technical specifications rather than diagnostic accuracy.
| Acceptance Criteria Category | Specific Metric (as per "Guidance for Industry and FDA Staff: Display Devices for Diagnostic Radiology") | Predicate Device (MDNC-6121) Performance | New Device (MDNC-12130) Performance | Result (Met/Not Met/Equivalent) |
|---|---|---|---|---|
| Basic Display Tech | Display Technology | a-Si TFT active matrix LCD with LED backlight | a-Si TFT active matrix LCD with LED backlight | Equivalent |
| Screen Size | Active screen size (diagonal) | 541 mm (21.3") | 784 mm (30.9") | Different (but intended improvement) |
| Active screen size (HxV) | 324.45 x 432.6 mm (12.77" x 17") | 653 x 435 mm (25.7 x 17.1") | Different (but intended improvement) | |
| Resolution | Resolution | 5.8 MP (2100 x 2800 pixels) | Native 12MP (4200 x 2800 pixels), Configurable to 2 x 5.8MP (2100 x 2800 pixels) | Improved (and backwards compatible) |
| Optical Characteristics | Maximum luminance (panel typical) | 1000 Cd/m² | 1200 Cd/m² | Improved |
| DICOM calibrated luminance | 600 Cd/m² | 600 Cd/m² | Equivalent | |
| Contrast ratio (panel typical) | 1400:1 | 1500:1 | Improved | |
| Latency/Response | Frame rate | 60 Hz (60 frames per second) | 60 Hz (60 frames per second) | Equivalent |
| Response time ((Tr + Tf)/2) (typical) Gray-to-gray | 12.5 ms | 10 ms | Improved | |
| Pixel Characteristics | Pixel array | 0.1545 x 0.1545 mm RGB pixel | 0.1554 x 0.1554 mm RGB pixel | Minor difference |
| Pixel pitch | 0.1545 mm | 0.1554 mm | Minor difference | |
| DPI (dots per inch) | 164 | 164 | Equivalent | |
| Subpixel pattern | 0.0515 x 0.1554 mm x 3 (RGB) | 0.0518 x 0.1554 mm x 3 (RGB) | Minor difference | |
| Pixel aperture ratio | 53.6% | 56.5% | Improved | |
| Interface/Calibration | Video input signals | DVI-D Dual Link (2x), DisplayPort (2x) | 2 x DisplayPort 1.2 | Different (modernized) |
| Ambient Light Sensor | Yes | Yes | Equivalent | |
| Luminance calibration and stabilization | Integrated Front sensor with luminance stabilization firmware | Integrated Front sensor with luminance stabilization firmware | Equivalent | |
| QA software | QAWeb | QAWeb | Equivalent | |
| Specific Performance Tests (Qualitative Reporting) | Spatial resolution – MTF | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) |
| Pixel defects, Artifacts | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Temporal Response | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Maximum and Minimum Luminance, Luminance response | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Conformance to DICOM GSDF | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Angular Dependency of Luminance | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Luminance uniformity | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Stability of Luminance and Chromaticity over Time and Operating Temperature | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Spatial Noise – NPS | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Reflection coefficient - Display Reflectance with Specular, Diffuse & Haze coefficients | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Veiling glare or small-spot contrast | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) | |
| Color tracking, Gray tracking | Not explicitly reported for predicate | "similar characteristics" | Met (comparable) |
Study Proving Device Meets Acceptance Criteria:
The study conducted is a bench testing comparison against the predicate device, following the "Guidance for Industry and FDA Staff: Display Devices for Diagnostic Radiology", issued on October 2, 2017.
-
Sample Size Used for the Test Set and Data Provenance:
- Sample Size: The document does not specify a quantitative "sample size" in terms of number of devices tested. It refers to "the modified device MDNC-12130" indicating at least one physical unit was tested. For display devices, typically a representative sample or a single unit is tested for performance specifications.
- Data Provenance: The testing was done internally by Barco N.V. (Belgium-based company). The data provenance is physical bench testing of the device itself.
- Retrospective or Prospective: This is a prospective test in the sense that a physical device was manufactured and its performance measured against established standards and the predicate device.
-
Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
- Not applicable in this context. The "ground truth" for a display device is its measured physical characteristics (e.g., luminance, resolution, contrast). These are objective measurements performed by specialized equipment, not by human experts creating a ground truth for diagnostic accuracy. The acceptance criteria (e.g., DICOM GSDF conformance) are established standards, not derived from expert consensus on a test set.
-
Adjudication Method for the Test Set:
- Not applicable. As noted above, the performance metrics of a display are objectively measured.
-
If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
- No, an MRMC study was NOT done. The document explicitly states: "No animal testing or clinical testing has been performed." An MRMC study involves human readers interpreting medical images with and without the device/AI assistance; this device is a display, not a diagnostic algorithm. Its function is to accurately render images, which is assessed via technical performance, not diagnostic accuracy by human readers.
-
If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- Yes, a standalone performance assessment was done. The entire "Performance testing" section (point 9 in the 510(k) Summary) describes the engineering bench tests performed on the MDNC-12130 as a standalone device to measure its optical and technical characteristics against the predicate and industry standards.
-
The Type of Ground Truth Used:
- The "ground truth" here is based on objective physical measurements and engineering specifications, benchmarked against industry standards (e.g., DICOM GSDF conformance, and the specific metrics outlined in the FDA's "Guidance for Industry and FDA Staff: Display Devices for Diagnostic Radiology"). The predicate device's performance also serves as a comparative "ground" for equivalence.
-
The Sample Size for the Training Set:
- Not applicable. This is a hardware display device, not an AI/machine learning algorithm that requires a "training set" of data.
-
How the Ground Truth for the Training Set was Established:
- Not applicable, as no training set was used.
{0}------------------------------------------------
November 10, 2020
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
Barco NV % Ms. Julie Vandecandelaere Regulatory Affairs Officer President Kennedypark 35 Kortrijk. W-VL 8500 BELGIUM
Re: K203106
Trade/Device Name: Nio Fusion 12MP (MDNC-12130) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: Class II Product Code: PGY Dated: October 8, 2020 Received: October 15, 2020
Dear Ms. Vandecandelaere:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
{1}------------------------------------------------
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K203106
Device Name Nio Fusion 12 MP (MDNC-12130)
Indications for Use (Describe)
The display is intended to be used in displaying digital images, including standard and multiframe digital mammography, for review, analysis, and diagnosis by trained medical practitioners. It is specially designed for breast tomosynthesis applications.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
BARCO
| 510(k) Summary (in accordance with 21 CFR 807.92) | |
|---|---|
| 1. Company | Barco N.V.Healthcare Division35 President KennedyparkB-8500 KortrijkBELGIUM |
| 2. Contact person | Julie VandecandelaereRegulatory Affairs OfficerTel: +32 (0)56 26 13 19julie.vandecandelaere@barco.com |
| 3. Date of submission | 08 October 2020 |
| 4. Device information | Trade name/model: Nio Fusion 12MP (MDNC-12130)Common name: MDNC-12130Classification name: System, image processing, RadiologicalClassification code: PGYRegulation number: 892.2050 |
| 5. Predicate device | Nio Color 5.8MP (MDNC-6121) cleared under 510(K) K170476. |
| 6. Device description | The MDNC-12130 (Nio Fusion 12MP) is a medical computer display designed for bothPACS and breast imaging applications.It consists of a 30.9" 12 mega-pixel (4200x2800 resolution) LCD panel with integratedLED backlight.The panel is integrated into the display housing body with an internal mechanics chassisstructure, that also integrates the electronics, sensors and power supply. The displaymodule is supported by a display stand.Internal sensors and controllers measure, control and stabilize the device.SoftGlow Lights are integrated as an ancillary function for user comfort and can be lit toilluminate the desk and to create some ambient lighting in the reading room.The 31" 12MP (4200x2800 resolution) MDNC-12130 display can be compared to a dual-head, 2 x 21″ 5.8 MP (2100x2800 resolution) MDNC-6121 display system.The MDNC-12130 is a derivative of the MDNC-6121.The modified display is effectively identical to the predicate device except for thefollowing changes:31" 12 mega-pixel (4200x2800 resolution) LCD panel, compared to 2 x 21inch5.8 MP LCD panel of a dual-head MDNC-6121 display system New housing, display stand and internal mechanics, with similar functionality anddesign principle compared to MDNC-6121 or any other Barco diagnostic display |
{4}------------------------------------------------
| ✓ Change in electronics board, with similar functionality and design principle compared to MDNC-6121 or any other Barco diagnostic display; including: | |||
|---|---|---|---|
| ✓ Integration of the power supply adaptor into the device, compared to an external power adapter for MDNC-6121 | |||
| ✓ Updated firmware, with similar functionality and design principle compared to MDNC-6121 or any other Barco diagnostic display | |||
| ✓ Change in packaging, with similar functionality and design principle compared to MDNC-6121 or any other Barco diagnostic display | |||
| ✓ Addition of SoftGlow Task Light and Wall Light ancillary function for user comfort | |||
| 7. Intended Use ofthe Device | The display is intended to be used in displaying and viewing digital images, including standard and multiframe digital mammography, for review, analysis, and diagnosis by trained medical practitioners. It is specially designed for breast tomosynthesis applications.Note: There are no changes to the indications for use statement from that of the unmodified device. | ||
| 8. Comparison oftechnologicalcharacteristics | Item | Predicate Device(K170476) | Device for which listing issought |
| Device name | Nio Color 5.8MP (MDNC-6121) | Nio Fusion 12MP (MDNC-12130) | |
| Display Technology | |||
| a-Si TFT active matrix LCDwith LED backlight | a-Si TFT active matrix LCD withLED backlight | ||
| Screen size | |||
| Active screen size(diagonal) | 541 mm (21.3") | 784 mm (30.9") | |
| Active screen size(HxV) | 324.45 x 432.6 mm (12.77" x17") | 653 x 435 mm (25.7 x 17.1") | |
| Aspect ratio (H: V) | 3:4 for each display in portraitmode, 3:2 overall for dualhead system | 3:2 | |
| Resolution | 5.8 MP (2100 x 2800 pixels) | Native 12MP (4200 x 2800pixels)Configurable to 2 x 5.8MP (2100x 2800 pixels) | |
| Optical characteristics | |||
| Maximumluminance (paneltypical) | 1000 Cd/m² | 1200 Cd/m² | |
| DICOM calibratedluminance | 600 Cd/m² | 600 Cd/m² | |
| Contrast ratio(panel typical) | 1400:1 | 1500:1 | |
| Frame rate and refresh rate | |||
| Frame rate | 60 Hz (60 frames per second) | 60 Hz (60 frames per second) | |
| Response time((Tr + Tf)/2)(typical)Gray-to-gray | 12.5 ms | 10 ms | |
| Pixel array, pitch, subpixel pattern, pixel aperture ratio | |||
| Pixel array | 0.1545 x 0.1545 mm RGB pixel | 0.1554 x 0.1554 mm RGB pixel | |
| Pixel pitch | 0.1545 mm | 0.1554 mm | |
| DPI (dots perinch) | 164 | 164 | |
| Subpixel pattern | 0.0515 x 0.1554 mm x 3(RGB) | 0.0518 x 0.1554 mm x 3 (RGB) | |
| Pixel apertureratio | 53.6% | 56.5% | |
| Display Interface | |||
| Video inputsignals | DVI-D Dual Link (2x)DisplayPort (2x) | 2 x DisplayPort 1.2 | |
| Ambient light sensing | |||
| Ambient LightSensor | Yes | Yes | |
| Luminance calibration tools | |||
| Front sensor | Yes | Yes | |
| Luminancecalibration andstabilization | Integrated Front sensor withluminance stabilizationfirmware | Integrated Front sensor withluminance stabilization firmware | |
| QAWeb quality controlsoftware (external) | QAWeb quality control software (external) | ||
| Quality-control procedures | |||
| QA software | QAWeb | QAWeb | |
| 9. Performancetesting | The technological characteristics discussed above show that the device MDNC-12130 has similar technological characteristics as the predicate device MDNC-6121 and do not reveal new issues of safety and performance. | ||
| The below performance bench tests are performed and corresponding results reported for the modified device MDNC-12130 in comparison to the predicate device MDNC-6121, as | |||
| per the instructions in "Guidance for Industry and FDA Staff: Display Devices forDiagnostic Radiology", issued on October 2, 2017: | |||
| Spatial resolution – MTF Pixel defects, Artifacts Temporal Response Maximum and Minimum Luminance, Luminance response Conformance to DICOM GSDF Angular Dependency of Luminance Luminance uniformity Stability of Luminance and Chromacity over Time and Operating Temperature Spatial Noise – NPS Reflection coefficient - Display Reflectance with Specular, Diffuse & Haze coefficients Veiling glare or small-spot contrast Color tracking, Gray tracking | |||
| The tests showed that the device has similar characteristics compared to the predicatedevice and did not reveal new issues of safety and performance.Additionally, the modified device MDNC-12130 is compliant to EMC and Safety standards. | |||
| No animal testing or clinical testing has been performed. | |||
| 10. Conclusion | The Nio Fusion 12MP (MDNC-12130) was found to be substantially equivalent to thepredicate device MDNC-6121, due to the following reasons:a) Device and predicate device have the same intended useb) The technological characteristics differences from the predicate device do not affectsafety or effectivenessc) Bench testing showed that the device has similar characteristics compared to thepredicate device and did not reveal new issues of safety and performance. |
Image /page/4/Picture/2 description: The image shows the word "BARCO" in white letters against a red background. The letters are bold and sans-serif. The "O" in BARCO has a unique design, with a circle and two small lines extending from it.
{5}------------------------------------------------
Image /page/5/Picture/2 description: The image shows the word "BARCO" in white letters against a red background. The letters are bold and sans-serif. The "O" in "BARCO" has a small circle inside it with a line extending from the top, resembling a stylized target or a technical symbol.
{6}------------------------------------------------
Image /page/6/Picture/2 description: The image shows the word "BARCO" in white letters against a red background. The letters are bold and sans-serif. The "O" in "BARCO" is stylized with a circle and two horizontal lines extending from either side.
ENABLING BRIGHT OUTCOMES
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).